NASDAQ : KLRA

Kailera Therapeutics, Inc.

$18.55 USD

$0.23 (1.26%)

Volume
342.89K
Average Volume
796.3K
Market Capitalization
$2.4B
P/E Ratio
-14.72
Dividend Yield
0.00%
Price Target
$42.00
Year High
$28.23
Year Low
$17.61
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$12.01
3333332"{? p/.m7yd f,0=

Annual earnings financials

KLRA financial data with annual/quarterly toggle

KLRA GAAP EPS - Annual & Quarterly

KLRA Sales Revenue - Annual & Quarterly

KLRA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

KLRA Estimated and Actual Revenue by Quarter
KLRA Estimated and Actual EPS by Quarter
KLRA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 0 - - - - - -
2028-09-30 0 - - - - - -
2028-06-30 0 - - - - - -
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
KLRA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 0 -168.4M -168.4M -168.4M - - -
2028-09-30 0 -156.25M -156.25M -156.25M - - -
2028-06-30 0 -139.56M -139.56M -139.56M - - -
2028-03-31 0 -140.95M -140.95M -140.95M - - -
2027-12-31 0 -142.36M -142.36M -142.36M - - -
2027-09-30 0 -142.98M -142.98M -142.98M - - -
KLRA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 0 - - - 1 -1.4277 -1.4277 -1.4277
2028-09-30 0 - - - 1 -1.3247 -1.3247 -1.3247
2028-06-30 0 - - - 1 -1.1832 -1.1832 -1.1832
2028-03-31 0 - - - 1 -1.195 -1.195 -1.195
2027-12-31 0 - - - 1 -1.207 -1.207 -1.207
2027-09-30 0 - - - 1 -1.2122 -1.2122 -1.2122